Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor–tyrosine kinase inhibitor resistance subclones
Abstract The dynamic nature of longitudinal tumor evolution across patients presents challenges in designing effective drugs. Here we aimed to determine tumor evolution resistance mechanisms and explore candidate drugs for specific tumor evolution types. We conducted longitudinal pharmacogenomic ana...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Experimental and Molecular Medicine |
| Online Access: | https://doi.org/10.1038/s12276-025-01493-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|